Melisi, D., Ossovskaya, V., Zhu, C., Rosa, R., Ling, J., Dougherty, P. M., . . . Chiao, P. J. (2009). Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity.

Melisi, Davide, Valeria Ossovskaya, Cihui Zhu, Roberta Rosa, Jianhua Ling, Patrick M. Dougherty, Barry M. Sherman, James L. Abbruzzese, and Paul J. Chiao. Oral Poly(ADP-ribose) Polymerase-1 Inhibitor BSI-401 Has Antitumor Activity and Synergizes With Oxaliplatin against Pancreatic Cancer, Preventing Acute Neurotoxicity. 2009.

Melisi, Davide, et al. Oral Poly(ADP-ribose) Polymerase-1 Inhibitor BSI-401 Has Antitumor Activity and Synergizes With Oxaliplatin against Pancreatic Cancer, Preventing Acute Neurotoxicity. 2009.